Biotech companies by P/E ratio

Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.

Exelixis has the lowest figure of the 9 biotech companies ranked by P/E ratio, at 20.6, followed by Halozyme Therapeutics (24.0) and Neurocrine Biosciences (24.1). Figures as of 18 Nov 2026, 20:27 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
9
Lowest
Exelixis20.6
Median
26.8
Combined market value
CHF 707.1B
Countries
5
Not ranked
15no P/E ratio on file

Market values as of .

All countries
All sectors
Biotech
CHF
Clear filters
Biotech companies by P/E ratio
#CompanyP/E ↑Market capPriceToday1 yearPrice, 30 daysCountry
1ExelixisEXEL · Health Care20.6CHF 14.1BCHF 57.88 0.21% up 63% up United States
2Halozyme TherapeuticsHALO · Health Care24.0CHF 9.2BCHF 81.10 0.23% up 37% up United States
3Neurocrine BiosciencesNBIX · Health Care24.1CHF 13.9BCHF 137.16 1.95% down 20% up United States
4AmgenAMGN · Health Care25.8CHF 202.9BCHF 375.15 2.83% down 34% up United States
5QiagenQGEN · Health Care26.8CHF 8.6BCHF 41.84 0.24% down 12% up Netherlands
6argenxARGX · Health Care32.7CHF 50.1BCHF 796.76 0.26% down 4% up Belgium
7Krystal BiotechKRYS · Health Care42.7CHF 7.9BCHF 265.19 5.35% up 46% up United States
8Bio-TechneTECH · Health Care66.8CHF 9.6BCHF 61.37 0.23% up 26% up United States
9BiogenBIIB · Health Care109CHF 31.2BCHF 211.38 0.03% down 49% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8431 CHF). 15 companies have no P/E ratio on file and are not ranked here.

Questions and answers

Which biotech companies have the lowest P/E ratio?

Exelixis (20.6), Halozyme Therapeutics (24.0) and Neurocrine Biosciences (24.1) have the lowest P/E ratio of the 9 biotech companies ranked here as of 18 Nov 2026, 20:27 UTC.

How many biotech companies are in this ranking?

9 are ranked by P/E ratio. 15 more have no P/E ratio on file and are left out rather than ranked at zero.

What are these biotech companies worth together?

The 9 biotech companies ranked by P/E ratio have a combined market value of CHF 707.1B as of 18 Nov 2026, 20:27 UTC.

What does ranking by P/E ratio measure?

Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.

Cite this page

Funkfolio, “Biotech companies by P/E ratio”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=pe-ratio

Underlying data: Yahoo Finance; SEC EDGAR.